<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font18">and </span>
   <span class="font16">for </span>
   <span class="font15">with </span>
   <span class="font13">The </span>
   <span class="font13">DAA </span>
   <span class="font13">treatment </span>
   <span class="font12">was </span>
   <span class="font12">therapy </span>
   <span class="font12">costs </span>
   <span class="font12">cost </span>
   <span class="font12">were </span>
   <span class="font12">SVR </span>
   <span class="font12">from </span>
   <span class="font12">patients </span>
   <span class="font11">study </span>
   <span class="font11">{background </span>
   <span class="font11">[]. </span>
   <span class="font11">cirrhosis </span>
   <span class="font11">data </span>
   <span class="font11">disease </span>
   <span class="font11">that </span>
   <span class="font11">model </span>
   <span class="font11">Health </span>
   <span class="font11">al. </span>
   <span class="font11">are </span>
   <span class="font11">triple </span>
   <span class="font11">hepatitis </span>
   <span class="font11">margin </span>
   <span class="font11">results </span>
   <span class="font11">this </span>
   <span class="font11">{border-style </span>
   <span class="font11">also </span>
   <span class="font11">This </span>
   <span class="font11">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">HCV </span>
   <span class="font10">Hepatitis </span>
   <span class="font10">effectiveness </span>
   <span class="font10">rates </span>
   <span class="font10">occupational </span>
   <span class="font10">years </span>
   <span class="font10">DAAs </span>
   <span class="font10">RWA </span>
   <span class="font10">analysis </span>
   <span class="font10">interferon-based </span>
   <span class="font10">therapies </span>
   <span class="font10">used </span>
   <span class="font10">using </span>
   <span class="font10">Markov </span>
   <span class="font10">SOF </span>
   <span class="font10">compared </span>
   <span class="font10">into </span>
   <span class="font10">pension </span>
   <span class="font10">Figure </span>
   <span class="font10">ICER </span>
   <span class="font10">Stahmeyer </span>
   <span class="font10">based </span>
   <span class="font10">carcinoma </span>
   <span class="font10">clinical </span>
   <span class="font10">have </span>
   <span class="font10">insured </span>
   <span class="font10">life </span>
   <span class="font10">medical </span>
   <span class="font10">over </span>
   <span class="font10">status </span>
   <span class="font10">benefits </span>
   <span class="font10">experience </span>
   <span class="font10">per </span>
   <span class="font10">treatments </span>
   <span class="font10">(SVR) </span>
   <span class="font10">... </span>
   <span class="font10">German </span>
   <span class="font10">Germany </span>
   <span class="font10">Table </span>
   <span class="font10">antiviral </span>
   <span class="font10">applied </span>
   <span class="font10">between </span>
   <span class="font10">chronic </span>
   <span class="font10">cohort </span>
   <span class="font10">higher </span>
   <span class="font10">information </span>
   <span class="font10">only </span>
   <span class="font10">regimens </span>
   <span class="font10">result </span>
   <span class="font10">treatment. </span>
   <span class="font10">CHC </span>
   <span class="font10">Decompensated </span>
   <span class="font10">For </span>
   <span class="font10">all </span>
   <span class="font10">associated </span>
   <span class="font10">available </span>
   <span class="font10">but </span>
   <span class="font10">comparison </span>
   <span class="font10">cost-effectiveness </span>
   <span class="font10">health </span>
   <span class="font10">high </span>
   <span class="font10">impact </span>
   <span class="font10">infection </span>
   <span class="font10">more </span>
   <span class="font10">not </span>
   <span class="font10">px; </span>
   <span class="font10">rate </span>
   <span class="font10">therapies. </span>
   <span class="font10">treated </span>
   <span class="font10">value </span>
   <span class="font10">{font-family </span>
   <span class="font10">BGW. </span>
   <span class="font10">Cirrhotic </span>
   <span class="font10">DAAs, </span>
   <span class="font10">These </span>
   <span class="font10">Treatment </span>
   <span class="font10">[,,,,] </span>
   <span class="font10">assumed </span>
   <span class="font10">font-size </span>
   <span class="font10">has </span>
   <span class="font10">hepatocellular </span>
   <span class="font10">literature </span>
   <span class="font10">model. </span>
   <span class="font10">outcomes </span>
   <span class="font10">present </span>
   <span class="font10">ribavirin </span>
   <span class="font10">such </span>
   <span class="font10">their </span>
   <span class="font10">values </span>
   <span class="font10">BGW </span>
   <span class="font10">Data </span>
   <span class="font10">Hepatocellular </span>
   <span class="font10">Non-cirrhotic </span>
   <span class="font10">[,]. </span>
   <span class="font10">[], </span>
   <span class="font10">additional </span>
   <span class="font10">after </span>
   <span class="font10">before </span>
   <span class="font10">benefit </span>
   <span class="font10">care </span>
   <span class="font10">cirrhotic </span>
   <span class="font10">der </span>
   <span class="font10">direct-acting </span>
   <span class="font10">diseases </span>
   <span class="font10">double; </span>
   <span class="font10">genotype </span>
   <span class="font10">had </span>
   <span class="font10">interferon-free </span>
   <span class="font10">most </span>
   <span class="font10">our </span>
   <span class="font10">overall </span>
   <span class="font10">patient </span>
   <span class="font10">payments </span>
   <span class="font10">regimen </span>
   <span class="font10">response </span>
   <span class="font10">second-generation </span>
   <span class="font10">sensitivity </span>
   <span class="font10">show </span>
   <span class="font10">therapy. </span>
   <span class="font10">total </span>
   <span class="font10">under </span>
   <span class="font10">(Figure </span>
   <span class="font10">A.N.; </span>
   <span class="font10">Analysis </span>
   <span class="font10">Cost </span>
   <span class="font10">Costs </span>
   <span class="font10">Efficiency </span>
   <span class="font10">Hepatol../j.jhep... </span>
   <span class="font10">LDV </span>
   <span class="font10">Liver </span>
   <span class="font10">Liver-related </span>
   <span class="font10">M.K., </span>
   <span class="font10">M.R., </span>
   <span class="font10">Public </span>
   <span class="font10">RBV </span>
   <span class="font10">Reporting </span>
   <span class="font10">Services </span>
   <span class="font10">Transplant </span>
   <span class="font10">Triple </span>
   <span class="font10">United </span>
   <span class="font10">[,,]. </span>
   <span class="font10">accident </span>
   <span class="font10">account </span>
   <span class="font10">advanced </span>
   <span class="font10">among </span>
   <span class="font10">analyse </span>
   <span class="font10">analysed </span>
   <span class="font10">analysis, </span>
   <span class="font10">annual </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">can </span>
   <span class="font10">cases </span>
   <span class="font10">death </span>
   <span class="font10">due </span>
   <span class="font10">group </span>
   <span class="font10">insurance </span>
   <span class="font10">interferon </span>
   <span class="font10">line </span>
   <span class="font10">liver </span>
   <span class="font10">long-term </span>
   <span class="font10">non-cirrhotic </span>
   <span class="font10">patients, </span>
   <span class="font10">percentage </span>
   <span class="font10">persons </span>
   <span class="font10">progression </span>
   <span class="font10">records </span>
   <span class="font10">resulted </span>
   <span class="font10">significant </span>
   <span class="font10">solid; </span>
   <span class="font10">statuses </span>
   <span class="font10">statutory </span>
   <span class="font10">studies </span>
   <span class="font10">study, </span>
   <span class="font10">taken </span>
   <span class="font10">than </span>
   <span class="font10">therefore </span>
   <span class="font10">these </span>
   <span class="font10">virologic </span>
   <span class="font10">weeks </span>
   <span class="font10">which </span>
   <span class="font10">will </span>
   <span class="font10">would </span>
   <span class="font10">years. </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">(in </span>
   <span class="font10">Based </span>
   <span class="font10">C.W., </span>
   <span class="font10">CEA </span>
   <span class="font10">Evaluation </span>
   <span class="font10">Gastroenterol. </span>
   <span class="font10">Germany. </span>
   <span class="font10">However, </span>
   <span class="font10">Institute </span>
   <span class="font10">Koch </span>
   <span class="font10">Medical </span>
   <span class="font10">Microsoft </span>
   <span class="font10">PEG-IFN </span>
   <span class="font10">Patients </span>
   <span class="font10">Percentage </span>
   <span class="font10">QALYs </span>
   <span class="font10">Quality </span>
   <span class="font10">Robert </span>
   <span class="font10">State </span>
   <span class="font10">Therapie </span>
   <span class="font10">Version </span>
   <span class="font10">Westermann </span>
   <span class="font10">[]; </span>
   <span class="font10">account. </span>
   <span class="font10">analyses </span>
   <span class="font10">analysis. </span>
   <span class="font10">application </span>
   <span class="font10">approximately </span>
   <span class="font10">average </span>
   <span class="font10">bold </span>
   <span class="font10">calculated </span>
   <span class="font10">case </span>
   <span class="font10">cohort, </span>
   <span class="font10">comparable </span>
   <span class="font10">correlation </span>
   <span class="font10">costs, </span>
   <span class="font10">courier; </span>
   <span class="font10">course </span>
   <span class="font10">decompensated </span>
   <span class="font10">determined </span>
   <span class="font10">developed </span>
   <span class="font10">direct </span>
   <span class="font10">drugs, </span>
   <span class="font10">effective </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">end </span>
   <span class="font10">findings </span>
   <span class="font10">future </span>
   <span class="font10">ijerph---t_Table </span>
   <span class="font10">indirect </span>
   <span class="font10">infected </span>
   <span class="font10">international </span>
   <span class="font10">may </span>
   <span class="font10">out </span>
   <span class="font10">pay </span>
   <span class="font10">pensions </span>
   <span class="font10">performed </span>
   <span class="font10">period </span>
   <span class="font10">probabilities </span>
   <span class="font10">pt;} </span>
   <span class="font10">ratio </span>
   <span class="font10">reduction </span>
   <span class="font10">regarding </span>
   <span class="font10">retrospective </span>
   <span class="font10">routine </span>
   <span class="font10">side </span>
   <span class="font10">stages </span>
   <span class="font10">standardised </span>
   <span class="font10">success </span>
   <span class="font10">takes </span>
   <span class="font10">therapy, </span>
   <span class="font10">those </span>
   <span class="font10">transition </span>
   <span class="font10">treatment, </span>
   <span class="font10">twelve </span>
   <span class="font10">und </span>
   <span class="font10">varied </span>
   <span class="font10">without </span>
   <span class="font10">work </span>
   <span class="font10">year) </span>
  </p>
 </body>
</html>
